1. "2004"
Formats
  1. Journal Article (1394)
  2. Meeting Abstract (554)
  3. Book Section (97)
  4. Conference Paper (14)
  5. Book Whole (6)
Groups
  1. Department of Medicine (558)
  2. Surgery (471)
  3. Sloan Kettering Institute Faculty (431)
  4. GSK Faculty (409)
  5. Solid Tumor Oncology Division (292)
  6. Survivorship Research (268)

More Groups

People
  1. Michael Kattan (43)
  2. Murray Brennan (42)
  3. Steven Larson (37)
  4. Peter Scardino (36)
  5. Carlos Cordon-Cardo (34)
  6. Michael Zelefsky (34)

More People

Years
  1. 2004 (2065)
Publications
  1. Journal of Clinical Oncology (170)
  2. Blood (94)
  3. Cancer Research (64)
  4. International Journal of Radiation Oncology, Biology, Physics (47)
  5. Medical Physics (36)
  6. Leibel and Phillips Textbook of Radiation Oncology. 2nd ed (35)

More Publications

Publishers
  1. Elsevier Inc. (261)
  2. American Society of Clinical Oncology (170)
  3. Lippincott Williams & Wilkins (126)
  4. Elsevier Science, Inc. (108)
  5. American Association for Cancer Research (106)
  6. Springer (105)

More Publishers

Results (2065)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Induction of mitotic defect is a novel anti-tumor mechanism of histone deacetylase inhibitor suberoylanilide hydroxamic acid
    Meeting Abstract

    Xu, W.; Perez, G.; Gui, C.; Thapi, D.; Ngo, L.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Screening of colorectal cancer: Progress and problems
    Meeting Abstract

    Winawer, S.
    EJC Supplements (2004)

    Fulltext@MSK | Save
  • CHIR 124, a novel and potent inhibitor of chk1, potentiates the anti-tumor activity of topoisomerase I poisons in vitro and in vivo
    Meeting Abstract

    Tse, A. N.; Embry, M.; Aardalen, K.; Shao, Y.; Rendahl, K.; Menezes, D.; Hibner, B.; Gesner, T.; Schwartz, G.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • 12-o-tetradecanoylphorbol 13-acetate (TPA)-induced decrease in Ataxia-telengiectasia mutated (ATM) protein levels is mediated by activation of protein kinase C alpha
    Meeting Abstract

    Truman, J.; Rotenberg, S.; Kolesnick, R.; Leibel, S.; Marquez, V. E.; Fuks, Z.; Haimovitz-Friedman, A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Transcriptional down-regulation of Ataxia-Telangiectasia Mutated protein (ATM) radiosensitizes human prostate cancer cells
    Meeting Abstract

    Truman, J.; Liao, W.; Ehleiter, D.; Kolesnick, R.; Lavin, M.; Leibel, S.; Fuks, Z.; Haimovitz-Friedman, A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Evaluation of potency and continence at 3 months following laparoscopic radical prostatectomy
    Meeting Abstract

    Touijer, K.; Trabulsi, E.; Hassen, W.; Saranchuk, J.; Guillonneau, B.
    European Urology, Supplements (2004)

    Fulltext@MSK | Save
  • Squamous cell carcinoma related oncogene (SCCRO) mediates angiogenesis through VEGF-A
    Meeting Abstract

    Talbot, S. G.; Sarkaria, I. S.; Pham, D.; Ngai, I.; O-Charoenrat, P.; Hezel, M.; Dudas, M.; Ghossein, R.; Socci, N.; Chuai, S.; more...
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Restoration of PTEN-expression in tumor cells causes them to depend on EGFR for suppression
    Meeting Abstract

    She, Q.; Moasser, M. M.; Ye, Q.; O'reilly, K.; Solit, D.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • P27 deficiency accelerates progression of prostate cancer initiated by SV40 large T antigen
    Meeting Abstract

    Shaffer, D. R.; Ishiwata, R.; Olgac, S.; Scher, H. I.; Koff, A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Analysis of EGFR/P13K signaling in bronchioloalveolar carcinoma progression and outcome
    Meeting Abstract

    Sarkaria, I. S.; Pham, D.; Talbot, S. G.; Hezel, M.; Patel, K. N.; Ebright, M. I.; Zakowski, M. F.; Chuai, S.; Memoli, N.; Miller, V. A.; more...
    Cancer Research (2004)

    Fulltext@MSK | Save